Field Medical Secures $35 Million in Series B Funding

Field Medical Closes $35 Million Series B Funding

Field Medical, Inc., a leader in next-generation cardiac ablation technology, has successfully closed a $35 million Series B financing round. This funding was co-led by BioStar Capital and Cue Growth, alongside contributions from existing strategic investors. The financial boost marks a significant step towards advancing the development of the FieldForce™ Ablation System and preparing for pivotal clinical trials as the company aims to expand treatment options for ventricular tachycardia (VT).

Investment Highlights and Objectives

The capital raised will facilitate the initiation of the pivotal VERITAS trial, support the further enhancement of the FieldForce Ablation System, and bolster Field Medical's clinical and regulatory framework. The impetus for this funding round was largely driven by strong pilot results that were presented at a recent industry meeting, which energized investor interest. With the Series B round, Field Medical has garnered a total of $75 million in capital, positioning itself as a frontrunner in pulsed field ablation innovation.

Leadership Insights on Future Directions

Steven Mickelsen, MD, the founder and CEO of Field Medical, highlighted the urgency and potential in VT treatment. "Ventricular tachycardia presents a significant gap in electrophysiology, where there is a pressing need for advanced solutions. Our next-generation therapy aims to address these needs with unparalleled speed and precision, paving the way for groundbreaking changes in how VT is managed for high-risk patients," he stated.

Louis Cannon, MD, from BioStar Capital, expressed excitement over Field Medical's innovative approach to addressing challenges within cardiology. He noted, "Field Medical’s physician-led team is uniquely positioned to transform VT treatment, leveraging their advanced technology and insights into physician needs." This partnership is expected to accelerate the company's growth and impact in the field.

Board of Directors Enhancements

In reaction to its accelerated growth, Field Medical has announced new appointments to its Board of Directors, further strengthening its leadership and strategic direction:

• Steven Mickelsen, MD – Founder and CEO, who has been instrumental in developing pulsed field ablation technologies.
• Mark Wisniewski – CFO of Enterra Medical, providing guidance through the next phase of value creation as board chairperson.
• Marlou Janssen – An experienced executive joining as a Board Member, bringing valuable expertise in product and clinical strategy.
• Alexei Mlodinow, MD, MBA – A seasoned investor with a history in medtech innovation.
• Ben Cannon – Founding Partner at Cue Growth, adding depth to the board with venture capital insights.

About Field Medical Inc.

Founded in 2022, Field Medical is dedicated to advancing pulsed field ablation (PFA) technologies targeted at complex cardiac arrhythmias. Led by pioneer Dr. Steven Mickelsen, the FieldForce™ Ablation System utilizes a cutting-edge catheter design along with proprietary energy efficiency to allow for rapid and direct ablation. The company has already secured Breakthrough Device Designation and was selected for the FDA TAP Pilot Program for its VT treatment, highlighting its commitment to innovation in cardiac care.

Frequently Asked Questions

What is the purpose of the recently closed Series B funding?

The $35 million funding aims to advance the FieldForce Ablation System, support pivotal clinical trials, and enhance clinical and regulatory capabilities.

Who are the key players in this funding round?

The funding round was co-led by BioStar Capital and Cue Growth, with support from existing investors.

What innovations does the FieldForce Ablation System offer?

The FieldForce Ablation System is designed for effective ventricular tachycardia treatment, utilizing next-generation pulsed field ablation technology for precise lesion creation.

What recent achievements has Field Medical accomplished?

Field Medical has raised a total of $75 million to date and received Breakthrough Device Designation from the FDA.

How is Field Medical prepared to tackle challenges in cardiology?

Field Medical is equipped with a strong team and state-of-the-art technology aimed at addressing unmet needs in VT care, driven by clinical insights and innovative solutions.

About The Author

Dedicated Author and financial expert Logan Wright here, 29 years old. After earning an economics degree, I spent a number of years working in different financial industries. My great passion is enabling everyone, from any background or experience level, to understand and be literate in financial matters.

My books and writings are centered on simplifying difficult financial ideas into doable, understandable guidance. Whether it's retirement planning, investing, or budgeting, I want to arm readers with the information they need to make wise financial choices and realize their financial objectives.

Apart from writing, I also frequently post to financial blogs and organize webinars and workshops targeted at enlightening participants about personal finance. Always, my strategy is to offer concise, doable advice that can truly improve people's lives.

Away from work, I like to read, travel, and sample new foods. My goal is to infuse everything I do with the balance that I think is essential to both financial and personal well-being. By my profession, I want to encourage and enable people to confidently and clearly take charge of their financial futures.

Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.